Fenucure Medical ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Fenucure Medical ApS
Fenucure Medical ApS (CVR number: 28486871) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of -911.9 kDKK in 2023. The operating profit was -2780 kDKK, while net earnings were -2108 kDKK. The profitability of the company measured by Return on Assets (ROA) was -69.7 %, which can be considered poor and Return on Equity (ROE) was -154.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -53.3 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Fenucure Medical ApS's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -2 412.30 | -2 428.82 | -1 714.36 | -1 590.48 | - 911.89 |
EBIT | -4 070.74 | -3 932.47 | -3 540.57 | -3 431.30 | -2 780.02 |
Net earnings | -3 236.22 | -3 181.26 | -4 542.75 | -3 548.69 | -2 107.95 |
Shareholders equity total | - 795.10 | - 976.37 | -2 519.11 | -3 567.80 | -1 675.76 |
Balance sheet total (assets) | 3 456.13 | 4 083.16 | 2 929.07 | 1 257.56 | 1 467.80 |
Net debt | 2 476.46 | 2 233.75 | 1 932.68 | 2 763.20 | 2 084.84 |
Profitability | |||||
EBIT-% | |||||
ROA | -95.7 % | -84.5 % | -67.4 % | -66.8 % | -69.7 % |
ROE | -93.6 % | -84.4 % | -129.6 % | -169.5 % | -154.7 % |
ROI | -147.7 % | -150.7 % | -131.4 % | -88.5 % | -69.7 % |
Economic value added (EVA) | -3 192.75 | -3 015.72 | -4 339.31 | -3 254.81 | -1 842.13 |
Solvency | |||||
Equity ratio | -18.7 % | -19.3 % | -46.2 % | -73.9 % | -53.3 % |
Gearing | -341.6 % | -252.4 % | -116.1 % | -80.7 % | -170.7 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.3 | 1.2 | 0.8 | 1.5 | 2.6 |
Current ratio | 1.5 | 1.4 | 1.0 | 3.9 | 3.9 |
Cash and cash equivalents | 239.81 | 230.32 | 993.15 | 115.61 | 776.25 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | B | B | B | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.